These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 1951239

  • 1. Elemental diet in steroid-dependent and steroid-refractory Crohn's disease.
    O'Brien CJ, Giaffer MH, Cann PA, Holdsworth CD.
    Am J Gastroenterol; 1991 Nov; 86(11):1614-8. PubMed ID: 1951239
    [Abstract] [Full Text] [Related]

  • 2. [Exclusive elemental enteral diet in cortico-resistant and cortico-dependent forms of Crohn's disease].
    Le Quintrec Y, Cosnes J, Le Quintrec M, Contou JF, Baumer P, Bellanger J, Gendre JP.
    Gastroenterol Clin Biol; 1987 Nov; 11(6-7):477-82. PubMed ID: 3111930
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 4. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 5. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM, Rogler G, Gross V, Gierend M, Bregenzer N, Andus T, Schölmerich J.
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [Abstract] [Full Text] [Related]

  • 6. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 7. Treatment of active Crohn's disease by exclusion diet.
    Beattie RM, Walker-Smith JA.
    J Pediatr Gastroenterol Nutr; 1994 Jul; 19(1):135-6. PubMed ID: 7965469
    [No Abstract] [Full Text] [Related]

  • 8. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 9. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA, Petritsch W, Aichbichler B, Fickert P, Ranner G, Krejs GJ.
    Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
    [Abstract] [Full Text] [Related]

  • 10. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience with infliximab therapy in 100 patients with Crohn's disease.
    Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P, Peppercorn MA.
    Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL, Chebli LA, Ribeiro MS, Pace FH, Moraes JP, do Amaral FJ, Gaburri PD, Meirelles de Souza AF, Chebli JM.
    Med Sci Monit; 2009 May; 15(5):PI19-26. PubMed ID: 19396048
    [Abstract] [Full Text] [Related]

  • 17. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
    Chrissafidou A, Malek M, Musch E.
    Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
    [Abstract] [Full Text] [Related]

  • 18. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
    Vilien M, Dahlerup JF, Munck LK, Nørregaard P, Grønbaek K, Fallingborg J.
    Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1147-52. PubMed ID: 15153167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.